| COVID-19 vaccination intent and perceptions among patients with inflammatory bowel diseases RS Dalal, E McClure, J Marcus, RW Winter, MJ Hamilton, JR Allegretti Clinical Gastroenterology and Hepatology 19 (8), 1730-1732. e2, 2021 | 63 | 2021 |
| Biosynthesis and genomic analysis of medium-chain hydrocarbon production by the endophytic fungal isolate Nigrograna mackinnonii E5202H JJ Shaw, DJ Spakowicz, RS Dalal, JH Davis, NA Lehr, BF Dunican, ... Applied microbiology and biotechnology 99, 3715-3728, 2015 | 57 | 2015 |
| Predictors of ustekinumab failure in Crohn’s disease after dose intensification RS Dalal, C Njie, J Marcus, S Gupta, JR Allegretti Inflammatory Bowel Diseases 27 (8), 1294-1301, 2021 | 42 | 2021 |
| Resveratrol regulates autophagy signaling in chronically ischemic myocardium AA Sabe, NY Elmadhun, RS Dalal, MP Robich, FW Sellke The Journal of thoracic and cardiovascular surgery 147 (2), 792-799, 2014 | 42 | 2014 |
| Predictors and outcomes of ustekinumab dose intensification in ulcerative colitis: a multicenter cohort study RS Dalal, S Esckilsen, EL Barnes, JC Pruce, J Marcus, JR Allegretti Clinical Gastroenterology and Hepatology 20 (10), 2399-2401. e4, 2022 | 35 | 2022 |
| Real-world comparison of tofacitinib vs ustekinumab among bio-exposed patients with ulcerative colitis: a propensity score analysis RS Dalal, J Mitri, H Goodrick, JR Allegretti Inflammatory Bowel Diseases 27 (10), 1694-1697, 2021 | 24 | 2021 |
| Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease RS Dalal, JR Allegretti Current opinion in gastroenterology 37 (4), 336-343, 2021 | 23 | 2021 |
| Hospitalization outcomes for inflammatory bowel disease in teaching vs nonteaching hospitals RS Dalal, RK Vajravelu, JD Lewis, GR Lichtenstein Inflammatory bowel diseases 25 (12), 1974-1982, 2019 | 18 | 2019 |
| Exposure to intravenous opioids is associated with future exposure to opioids in hospitalized patients with inflammatory bowel diseases RS Dalal, S Palchaudhuri, CK Snider, JD Lewis, SJ Mehta, ... Clinical Gastroenterology and Hepatology 18 (10), 2269-2278. e3, 2020 | 17 | 2020 |
| Investigating the effects of resveratrol on chronically ischemic myocardium in a swine model of metabolic syndrome: a proteomics analysis AA Sabe, AA Sadek, NY Elmadhun, RS Dalal, MP Robich, C Bianchi, ... Journal of medicinal food 18 (1), 60-66, 2015 | 17 | 2015 |
| A user-friendly prediction tool to identify colectomy risk in patients with ulcerative colitis RS Dalal, MT Osterman, AM Buchner, A Praestgaard, JD Lewis, ... Inflammatory Bowel Diseases 25 (9), 1550-1558, 2019 | 13 | 2019 |
| Does resveratrol improve insulin signaling in chronically ischemic myocardium? AA Sabe, NY Elmadhun, MP Robich, RS Dalal, FW Sellke Journal of Surgical Research 183 (2), 531-536, 2013 | 12 | 2013 |
| Outcomes of standard and intensified dosing of ustekinumab for chronic pouch disorders RS Dalal, S Gupta, H Goodrick, J Mitri, JR Allegretti Inflammatory Bowel Diseases 28 (1), 146-149, 2022 | 11 | 2022 |
| Preoperative gene expression may be associated with neurocognitive decline after cardiopulmonary bypass AA Sabe, RS Dalal, LM Chu, NY Elmadhun, B Ramlawi, C Bianchi, ... The Journal of thoracic and cardiovascular surgery 149 (2), 613-623, 2015 | 11 | 2015 |
| Effects of alcohol on postoperative adhesion formation in ischemic myocardium and pericardium NY Elmadhun, AA Sabe, AD Lassaletta, RS Dalal, FW Sellke The Annals of Thoracic Surgery 104 (2), 545-552, 2017 | 10 | 2017 |
| Comparative long-term drug survival of vedolizumab, adalimumab, and infliximab in biologic-naïve patients with ulcerative colitis RS Dalal, EL McClure, J Marcus, JR Allegretti Digestive Diseases and Sciences 68 (1), 223-232, 2023 | 8 | 2023 |
| Tofacitinib for the treatment of pouch-related disorders: a case series RS Dalal, K Bains, J Marcus, EL McClure, JR Allegretti Inflammatory Bowel Diseases 28 (11), 1787-1789, 2022 | 8 | 2022 |
| Preadmission cannabis use is positively correlated with inpatient opioid dose exposure in hospitalized patients with inflammatory bowel diseases RS Dalal, S Palchaudhuri, CK Snider, JD Lewis, SJ Mehta, ... Inflammatory Bowel Diseases 27 (4), 500-506, 2021 | 8 | 2021 |
| A multimodal intervention using nonopioid analgesics is associated with reduced intravenous opioid exposure among hospitalized patients with inflammatory bowel diseases RS Dalal, S Palchaudhuri, CK Snider, Y Gitelman, M Brahmbhatt, NK Mull, ... Official journal of the American College of Gastroenterology| ACG 115 (9 …, 2020 | 8 | 2020 |
| Long-term outcomes after ustekinumab dose intensification for inflammatory bowel diseases RS Dalal, JC Pruce, JR Allegretti Inflammatory Bowel Diseases 29 (5), 830-833, 2023 | 6 | 2023 |
